Search research articles
Contact Us
Filters
Showing results (81-90 of 108) with videos related to
Page
of 11
Sort By:
Nature Communications
|
December 13, 2019
The autophagy receptor p62/SQST-1 promotes proteostasis and longevity in C. elegans by inducing autophagy
Caroline Kumsta, Jessica T Chang, Reina Lee, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 15, 2006
Phase II trial of irinotecan plus oxaliplatin and 5-fluorouracil/leucovorin in patients with untreated metastatic gastric adenocarcinoma
J Lee, W K Kang, J M Kwon, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
March 6, 2022
A Comparison of Folinic Acid, Fluorouracil and Irinotecan (FOLFIRI) plus Bevacizumab and FOLFIRI plus Aflibercept as Second-line Treatment for Metastatic Colorectal Cancer
H Jo, M-S Lee, Y-P Lee, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 10, 2012
Multicenter phase II study of sunitinib in patients with non-clear cell renal cell carcinoma
J-L Lee, J-H Ahn, H Y Lim, et al.
Neoplasma
|
January 18, 2006
The addition of induction chemotherapy with etoposide, ifosfamide, and cisplatin failed to improve therapeutic outcome of concurrent chemoradiotherapy in patients with locally advanced non-small cell lung cancer -- single institution retrospective analysis
H-W Lee, J-H Choi, H-Y Lim, et al.
Cancer Chemotherapy and Pharmacology
|
February 8, 2011
Different relation between ERCC1 overexpression and treatment outcomes of two platinum agents in advanced biliary tract adenocarcinoma patients
I G Hwang, J S Jang, J H Do, et al.
ESMO Gastrointestinal Oncology
|
April 17, 2026
Regorafenib use in patients with unresectable hepatocellular carcinoma: analyses of subgroups of special interest in the observational REFINE study
Y J Kim, P Merle, R S Finn, et al.
International Journal of Oncology
|
September 24, 1999
Changes of telomerase and telomere lengths in paired normal and cancer tissues of breast
S Y Rha, K H Park, T S Kim, et al.
American Journal of Clinical Oncology
|
February 1, 1996
Gastric cancer in young patients who underwent curative resection. Comparative study with older patients
J H Choi, H C Chung, N C Yoo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 15, 2013
A randomized phase II study of PEP02 (MM-398), irinotecan or docetaxel as a second-line therapy in patients with locally advanced or metastatic gastric or gastro-oesophageal junction adenocarcinoma
A C Roy, S R Park, D Cunningham, et al.
Page
of 11
Search research articles
Search
Showing results (81-90 of 108) with videos related to
Sort By:
Page
of 11
Nature Communications
|
December 13, 2019
The autophagy receptor p62/SQST-1 promotes proteostasis and longevity in C. elegans by inducing autophagy
Caroline Kumsta, Jessica T Chang, Reina Lee, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 15, 2006
Phase II trial of irinotecan plus oxaliplatin and 5-fluorouracil/leucovorin in patients with untreated metastatic gastric adenocarcinoma
J Lee, W K Kang, J M Kwon, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
March 6, 2022
A Comparison of Folinic Acid, Fluorouracil and Irinotecan (FOLFIRI) plus Bevacizumab and FOLFIRI plus Aflibercept as Second-line Treatment for Metastatic Colorectal Cancer
H Jo, M-S Lee, Y-P Lee, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 10, 2012
Multicenter phase II study of sunitinib in patients with non-clear cell renal cell carcinoma
J-L Lee, J-H Ahn, H Y Lim, et al.
Neoplasma
|
January 18, 2006
The addition of induction chemotherapy with etoposide, ifosfamide, and cisplatin failed to improve therapeutic outcome of concurrent chemoradiotherapy in patients with locally advanced non-small cell lung cancer -- single institution retrospective analysis
H-W Lee, J-H Choi, H-Y Lim, et al.
Cancer Chemotherapy and Pharmacology
|
February 8, 2011
Different relation between ERCC1 overexpression and treatment outcomes of two platinum agents in advanced biliary tract adenocarcinoma patients
I G Hwang, J S Jang, J H Do, et al.
ESMO Gastrointestinal Oncology
|
April 17, 2026
Regorafenib use in patients with unresectable hepatocellular carcinoma: analyses of subgroups of special interest in the observational REFINE study
Y J Kim, P Merle, R S Finn, et al.
International Journal of Oncology
|
September 24, 1999
Changes of telomerase and telomere lengths in paired normal and cancer tissues of breast
S Y Rha, K H Park, T S Kim, et al.
American Journal of Clinical Oncology
|
February 1, 1996
Gastric cancer in young patients who underwent curative resection. Comparative study with older patients
J H Choi, H C Chung, N C Yoo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 15, 2013
A randomized phase II study of PEP02 (MM-398), irinotecan or docetaxel as a second-line therapy in patients with locally advanced or metastatic gastric or gastro-oesophageal junction adenocarcinoma
A C Roy, S R Park, D Cunningham, et al.
Page
of 11